Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine: case report-Reference-Cited by-同舟云学术

Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine: case report

Published:1999-09 Issue:3B Volume:57 Page:863-866
ISSN:0004-282X
Container-title:Arquivos de Neuro-Psiquiatria
language:
Short-container-title:Arq. Neuro-Psiquiatr.

Author:

ETCHEBEHERE ELBA C. S. C.¹,LIMA MARIANA C. L.¹,PASSOS WALMIR¹,MACIEL JR JAIME A.¹,SANTOS ALLAN O.¹,RAMOS CELSO DARÍO¹,CAMARGO EDWALDO E.¹

Affiliation:

1. Universidade Estadual de Campinas (UNICAMP)

Abstract

Olanzapine, an atypical antipsychotic drug, was administered to a patient with Huntington's disease (HD) with marked choreiform movements. Brain SPECT with 99mTc-HMPAO was performed before and after treatment. Brain SPECT imaging has been performed in patients with HD in order to determine the status of basal ganglia perfusion. The use of brain SPECT with 99mTc-HMPAO before and after treatment in patients with HD has not been yet reported. The marked hypoperfusion of the basal ganglia on brain SPECT performed before therapy with olanzapine improved significantly after treatment.

Publisher

FapUNIFESP (SciELO)

Subject

Neurology,Neurology (clinical)

Link

http://www.scielo.br/pdf/anp/v57n3b/1200.pdf

Reference7 articles.

1. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease;Harris GJ;Arch Neurol,1996

2. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans;Nagel JS;Semin Nucl Med,1991

3. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease;Ichise M;J Nucl Med,1993

4. SPECT with HMPAO compared to PET with FDG in Huntington disease;Boecker H;J Comput Assist Tomogr,1994

5. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients;Botsch H;ROFO Fortschr Geb Rontgenstr Nuklearmed,1987

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?;Movement Disorders;2014-08-27

2. Treatment of Huntington Disease;Current Treatment Options in Neurology;2013-02-16

3. Symptomatic treatment of Huntington disease;Neurotherapeutics;2008-04

4. A systematic review of the treatment studies in Huntington’s disease since 1990;Expert Opinion on Pharmacotherapy;2007-01-26

5. Pharmacological Management of Huntingtons Disease: An Evidence- Based Review;Current Pharmaceutical Design;2006-07-01